NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Joe Biden
    United States of America
    COVID-19
    Russia-Ukraine crisis
    NewsBytes
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / World News / AstraZeneca resumes clinical trials for COVID-19 vaccine after UK nod
    World

    AstraZeneca resumes clinical trials for COVID-19 vaccine after UK nod

    AstraZeneca resumes clinical trials for COVID-19 vaccine after UK nod
    Written by Siddhant Pandey
    Sep 12, 2020, 08:44 pm 2 min read
    AstraZeneca resumes clinical trials for COVID-19 vaccine after UK nod

    Late-stage clinical trials of a COVID-19 vaccine being developed by the drug firm AstraZeneca and the University of Oxford have resumed. AstraZeneca said in a statement on Saturday that the clinical trials had been resumed in the United Kingdom after a nod from British regulators. Earlier this week, the firm had announced that it was putting a halt on the clinical trials.

    'UK committee concluded trials are safe to resume'

    AstraZeneca said on Saturday, "Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so." The statement added, "The UK committee has concluded its investigations and recommended to the MHRA that trials in the UK are safe to resume."

    AstraZeneca said it cannot disclose further medical information

    AstraZeneca said that neither it nor Oxford University can disclose further medical information. "All trial investigators and participants will be updated with the relevant information and this will be disclosed on global clinical registries, according to the clinical trial and regulatory standards," the firm said.

    Committed to safety of trial participants: AstraZeneca

    Further, AstraZeneca assured that it is "committed to the safety of trial participants and the highest standards of conduct in clinical trials." It said, "The company will continue to work with health authorities across the world and be guided as to when other clinical trials can resume to provide the vaccine broadly, equitably and at no profit during this pandemic."

    What is the vaccine?

    Oxford University and AstraZeneca are developing a COVID-19 vaccine, called AZD1222. The potential vaccine consists of the replication-deficient chimpanzee viral vector (ChAdOx1) based on a weakened version of a common cold virus (adenovirus) containing the genetic material of the SARS-CoV-2 virus spike protein. After vaccination, the spike protein produced triggers an immune response that offers protection against future SARS-CoV-2 infections.

    Trials were halted after volunteer fell ill

    On Tuesday, it was announced that the clinical trials for AZD1222 had been halted. Reportedly, a trial volunteer had fallen ill after receiving the potential vaccine. Thereafter, the Pune-based Serum Institute of India (SII) had also paused the vaccine's combined phase 2 and 3 clinical trials in India. The Drugs Controller General of India (DCGI) had also asked SII to suspend recruitment in clinical trials.

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Latest
    Vaccine
    Oxford University
    University of Oxford
    Coronavirus

    Latest

    Alphonse Puthren announces his next project; details inside Tamil Cinema
    OTT: Ananya Panday's 'Call Me Bae' is filming now OTT releases
    Box office: 'Kabzaa' sees rise in collections Box Office
    World's first 3D-printed rocket launched but didn't reach orbit Space News

    Vaccine

    Gurugram: Woman confined herself, son for 3 years fearing COVID-19 Gurugram
    India's 1st nasal COVID-19 vaccine by Bharat Biotech launched COVID-19
    US approves world's first vaccine for honey bees United States of America
    Delhi: Government centers run out of free COVID-19 booster vaccine Delhi

    Oxford University

    Cambridge Dictionary alters 'man' and 'woman' definitions, faces criticism Social Media
    COVID-19 vaccine maker Professor Sarah Gilbert honored with Barbie doll COVID-19
    #OxfordUniversity racism row: India to raise the issue when required S Jaishankar
    Severe side-effects after COVID-19 vaccine: What are your legal options? Serum Institute of India

    University of Oxford

    COVID-19 increases risk of brain fog, dementia: Study COVID-19
    Oxford University testing COVID-19 vaccine in children Coronavirus
    Over 10 lakh inoculated, India's vaccination drive picks pace India
    Sleeves up! Coronavirus vaccination drive could begin on January 13 Union Health Ministry

    Coronavirus

    PM Modi to hold high-level meeting amid rising COVID-19 cases Narendra Modi
    India reports highest daily COVID-19 cases in 2023: Check tally COVID-19 India
    COVID-19 subvariant XBB 1.16 cases rise in India; guidelines revised COVID-19
    WHO lambasts China for allegedly hiding data on COVID-19's origin World Health Organization

    Love World News?

    Subscribe to stay updated.

    World Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023